XML 53 R134.htm IDEA: XBRL DOCUMENT v3.20.1
Note 29 - Segment Information - Schedule of Segment Reporting Information By Segment (Details) - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues € 44,912 € 39,183 € 35,746
Cost of sales (23,909) (22,266) (20,938)
Gross profit 21,002 16,917 14,808
Research and development expenses (3,728) (4,088) (3,881)
Selling and marketing expenses (10,850) (10,551) (9,526)
General and administrative expenses (4,224) (3,593) (3,428)
Segment operating income (loss) 2,201 (1,315) (2,027)
Total Assets 53,068 48,740  
Goodwill 2,412 2,412  
Product [Member]      
Revenues 30,111 25,070 22,580
Cost of sales (15,442) (14,053) (13,170)
HIFU Treatments and Devices Leased [Member]      
Revenues 5,747 5,086 5,095
Cost of sales (3,000) (2,557) (2,667)
Parts and Services [Member]      
Revenues 9,001 9,007 8,011
Cost of sales (5,467) (5,655) (5,101)
Product and Services, Excluding Other [Member]      
Revenues 44,859 39,163 35,686
Product and Service, Other [Member]      
Revenues 52 19 60
High Intensity Focused Ultrasound (HIFU) [Member]      
Revenues 14,144 11,044 9,513
Cost of sales (6,152) (5,312) (4,732)
Gross profit 7,991 5,732 4,782
Research and development expenses (1,962) (2,394) (2,469)
Selling and marketing expenses (4,402) (4,628) (4,004)
General and administrative expenses (1,168) (1,036) (1,009)
Total expenses (7,533) (8,057) (7,482)
Segment operating income (loss) 459 (2,325) (2,701)
Total Assets 16,665 13,648 11,333
Capital expenditures 915 1,154 1,190
Long-lived assets 4,096 2,855 2,804
Goodwill 645 645 645
High Intensity Focused Ultrasound (HIFU) [Member] | Product [Member]      
Revenues 8,311 5,494 4,232
High Intensity Focused Ultrasound (HIFU) [Member] | HIFU Treatments and Devices Leased [Member]      
Revenues 4,162 3,750 3,800
High Intensity Focused Ultrasound (HIFU) [Member] | Parts and Services [Member]      
Revenues 1,618 1,780 1,445
High Intensity Focused Ultrasound (HIFU) [Member] | Product and Services, Excluding Other [Member]      
Revenues 14,092 11,025 9,477
High Intensity Focused Ultrasound (HIFU) [Member] | Product and Service, Other [Member]      
Revenues 52 19 36
Urology Devices and Services (UDS) [Member]      
Revenues 30,768 28,139 26,233
Cost of sales (17,757) (16,954) (16,207)
Gross profit 13,011 11,185 10,026
Research and development expenses (1,766) (1,694) (1,413)
Selling and marketing expenses (6,448) (5,923) (5,521)
General and administrative expenses (1,758) (1,311) (1,057)
Total expenses (9,972) (8,928) (7,991)
Segment operating income (loss) 3,039 2,257 2,035
Total Assets 32,392 29,849 27,803
Capital expenditures 617 775 928
Long-lived assets 6,875 5,158 4,278
Goodwill 1,767 1,767 1,767
Urology Devices and Services (UDS) [Member] | Product [Member]      
Revenues 21,800 19,576 18,348
Urology Devices and Services (UDS) [Member] | HIFU Treatments and Devices Leased [Member]      
Revenues 1,585 1,336 1,295
Urology Devices and Services (UDS) [Member] | Parts and Services [Member]      
Revenues 7,383 7,227 6,566
Urology Devices and Services (UDS) [Member] | Product and Services, Excluding Other [Member]      
Revenues 30,768 28,139 26,209
Urology Devices and Services (UDS) [Member] | Product and Service, Other [Member]      
Revenues 24
EDAP Technomed Co Ltd. [Member]      
Revenues
Cost of sales
Gross profit
Research and development expenses
Selling and marketing expenses
General and administrative expenses (1,297) (1,246) (1,362)
Total expenses (1,297) (1,246) (1,362)
Segment operating income (loss) (1,297) (1,246) (1,362)
Total Assets 4,012 5,243 7,761
Capital expenditures
Long-lived assets
Goodwill
EDAP Technomed Co Ltd. [Member] | Product [Member]      
Revenues
EDAP Technomed Co Ltd. [Member] | HIFU Treatments and Devices Leased [Member]      
Revenues
EDAP Technomed Co Ltd. [Member] | Parts and Services [Member]      
Revenues
EDAP Technomed Co Ltd. [Member] | Product and Services, Excluding Other [Member]      
Revenues
EDAP Technomed Co Ltd. [Member] | Product and Service, Other [Member]      
Revenues
FDA [Member]      
Revenues 44,912 39,183 35,746
Cost of sales (23,909) (22,266) (20,938)
Gross profit 21,002 16,917 14,808
Research and development expenses (3,728) (4,088) (3,881)
Selling and marketing expenses (10,850) (10,551) (9,526)
General and administrative expenses (4,224) (3,593) (3,428)
Total expenses (18,802) (18,232) (16,835)
Segment operating income (loss) 2,201 (1,315) (2,027)
Total Assets 53,068 48,740 46,897
Capital expenditures 1,532 1,928 2,118
Long-lived assets 10,971 8,013 7,082
Goodwill 2,412 2,412 2,412
FDA [Member] | Product [Member]      
Revenues 30,111 25,070 22,580
FDA [Member] | HIFU Treatments and Devices Leased [Member]      
Revenues 5,747 5,086 5,095
FDA [Member] | Parts and Services [Member]      
Revenues 9,001 9,007 8,011
FDA [Member] | Product and Services, Excluding Other [Member]      
Revenues 44,859 39,163 35,686
FDA [Member] | Product and Service, Other [Member]      
Revenues € 52 € 19 € 60